PPT-Management of Chemotherapy-Induced Peripheral Neuropathy: Assessment & Treatment

Jessica Latchman APRN AGACNPBC AOCNP ACHPN Ann Guastella APRN AOCN ACHPN December 13 2022 INTRODUCTION Chemotherapy induced peripheral Neuropathy is common problem facing cancer patients . Sensory Neuropathy . Sandra E. Kurtin, RN, MS, AOCN. ®. , ANP-C. Clinical Assistant Professor of Medicine. Adjunct Clinical Assistant Professor of Nursing. Nurse Practitioner. The University of Arizona Cancer Center. BEMER Therapy RESULTS. From the Liebman Wellness Center. Dr. Jesse Liebman, DC. Dr. Derek Bruno, DC. The patient’s initial exam: 9/10/15. During the initial evaluation, the skin condition was so deteriorated that the patient had to wrap his legs in 10+ layers of gauze and wear multiple socks to keep them from oozing through the bandages.. Kathleen Brandfass, MS PT . Director of Neuro,Vestibular and Geriatric Outpatient Services. UPMC/Centers for Rehab Services . Objectives. 1. Review Case presentation of Chemo Induced Peripheral Neuropathy (CIPN). Winter Weekend 2017. Saratoga Springs, NY. John D. Ruiz, . MD. New York, NY. Goals of the hour . List and review types of neuropathy. Define neuropathy. Look at presentation of different types of neuropathy. 1characteristic pattern of numbness is one in which the distal portions of the nerves are first affected the socalled stockingglovepattern This pattern occurs because nerve fibers are affected accord You . Peter Argenta, MD. Definition. The conditions that result when nerves that carry messages to and from the brain and spinal cord from and to the rest of the body are damaged or diseased.. What does it mean for patients?. VAHID SALEHIFAR MD. NEUROLOGIST. FARABI HOSPITAL. Anatomy. Introduction. Common neurological problems. Disordered function and structure of motor, sensory, and autonomic nerves. Causes are . disparate,presentations. Head, Palliative Care Research. Division of Cancer Prevention. NCI: Programmatic Overview of CIPN Portfolio. . March. , 2017. Objectives. Provide an overview of the NCI Community Oncology Research Program (NCORP).  . Dr.Thabat. J. Al-. Maiahy. MBChB,DOG,CABOG. Radiotherapy. EXTERNAL RADIATION THERAPY. Indicated when an area to be irradiated is large, . e.g. cx cancer . The basic tent of radiation therapy is to maximize the tumor damage while minimizing the . General informations . about anatomy, physyology and pathology of the peripheral nervous system. Polineuropathies. (general features, genetic neuropathies, diabethic neuropathy, diagnosis and avaluation of the peripheral nervous system. March 23, 2017. Jennifer Gewandter, PhD, MPH. Presentation objectives. Outline the design challenges and issues to consider when designing a CIPN study during chemotherapy. Summarize how published RCTs have addressed these design challenges. over 55 years of neuropathic toxicity: . if not now, when do we take . aaacttion. . Joanna M . Brell. , MD. Clinical Associate Professor of medicine. Case Western Reserve University. Associate Director Cancer Center for clinical research. Pamela Horn, MD. Clinical Reviewer. DAAAP. Outline. Patient Perspective from PFDD Public Meeting. Drug Approval Standards. Approved Therapies. Possible CIPN Indications. FDA Review Division Roles. Study Design Issues Raised by Sponsors. n. ges in Clinical . T. rials for CIPN. Michael P. McDermott, Ph.D.. University of Rochester Medical Center. Measurement of outcome. Strategies for statistical analysis. Defining the study population.